VITA 34 AG: VITA 34 Increases Profit in Third Quarter of 2011

Leipzig, (PresseBox) - .
- Positive group result of approximately EUR 1 million following EUR 0.03 million
- Earnings before interest and taxes [EBIT] also increased
- Revenues of EUR 4.3 million at prior year's level
- Positive group results expected for full year 2011

VITA 34 AG (ISIN DE000A0BL849, the oldest private umbilical cord blood bank in the German-speaking countries, has increased its profits in the third quarter of 2011 as compared with the prior year, and has earned revenues at the level of the previous year. The group result of EUR 0.96 million in the reporting period was significantly higher than the prior year's result of EUR 0.03 million. The earnings before interest and taxes, EBIT, of EUR 0.24 million in Q3 2011 also exceeded the prior year's level of EUR 0.19 million. Thus, in Q3 2011 VITA 34 was again successful in posting numbers in the black, after having to post losses in the first and second quarters of 2011. Revenues of EUR 4.33 nearly reached the level of the third quarter of 2010.

The development in Italy, where VITA 34 works together with its partner Sorgente S.r.l., was pleasing. The storage figures and the revenue from this region in the third quarter was significantly higher than in the prior year's quarter and, when considering the period from January to September 2011, even more than double that of the same period the year before. This positive trend should continue in the further course of the year.

The number of storages in the third quarter 2011 of 2,363 did exceed the value of each of the first two quarters of 2011, however, it was not possible to attain the prior year's level of 3,141 storages. The reasons for this were declining storage figures from Spain due to the tense economic situation there, and reticence with regard to private preventative expenditures in the German home market. In addition, storage for the Norddeutsche Knochenmark- und Stammzellregister (NKR - North German Bone Marrow and Stem Cell Registry), was fully eliminated in 2011.

The umbilical cord blood storages in the first nine months of 2011 were 6,840 preparations following 8,293 in the prior year. Revenues of EUR 12.1 were slightly higher than the level of the prior year of EUR 12.0 million. EBIT in the first nine months of 2011 was EUR -0.4 million, following EUR 0.4 million in the first nine months of 2010. In the reporting period a positive group result of EUR 0.5 million was posted. A group result of EUR 0.2 million was attained in the prior year's period.

VITA 34 expects a positive group result for the full year 2011. Revenues will most likely be below the level of record year 2010.

The complete quarterly report is available for download at www.vita34group.com.

Press releases you might also be interested in

Subscribe for news

The subscribtion service of the PresseBox informs you about press information of a certain topic by your choice at a choosen time. Please enter your email address to receive the email with the press releases.

An error occurred!

Thank you! You will receive a confirmation email within a few minutes.


I want to subscribe to the gratis press mail and have read and accepted the conditions.